The Global Medtech Industry: Rewiring Medtech in a Post-Pandemic World
The medtech industry is undergoing rapid change to address evolving global market dynamics. This has been further accelerated by the pandemic. This white paper from IQVIA – an associate member of AdvaMed® – discusses how global markets and specific therapeutic areas are poised for growth over the next decade. Read this white paper to help inform business strategy.
Related Reading
Global & Trade
Support for Medical Supply and Equipment Needs in Namibia
Review Namibia’s current medical device and equipment needs and learn how interested companies can provide support for medical supply and equipment needs in Namibia.
Resource / China / Global & Trade / Regulatory Affairs / Standards
China GMP and ISO 13485: A Side-by-Side Comparison
June 22, 2026
China GMP and ISO 13485: A Side-by-Side Comparison
Blog / Emerging Policy Response Resources / Global & Trade / Tariffs
IEEPA Tariff Refunds Summary – What MedTech Companies Need to Know
April 29, 2026
After the Supreme Court struck down IEEPA tariffs, CBP launched the CAPE system to process refunds. Here’s what importers need to know about eligibility, submission, and timing.
Resource / AdvaMed Advancements / Emerging Policy Response Resources / Global & Trade / Tariffs
AdvaMed® Advancements: Q1 2026 Report
April 24, 2026
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
IEEPA Tariff Refunds Are Coming: What Medtech Needs to Know
Now On-Demand
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, learn what that means for your organization.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
Navigating the ACCESS & TEMPO Models: A Direct Dialogue with CMMI & FDA Leaders
On Demand
Watch AdvaMed’s® exclusive member-only webinar featuring a direct dialogue with CMS Innovation Center leadership on the newly released ACCESS & TEMPO Model. Attendees will gain critical insights into model performance metrics, payment pathways, and opportunities for the MedTech industry.
News / Global & Trade / Tariffs
ICYMI: AdvaMed’s Scott Whitaker on Supreme Court Tariffs Decision, Next Steps
February 23, 2026
Scott Whitaker, president and CEO ofAdvaMed®, the world’s largest trade association representing medtech innovators, released the following statement after Fridays’ Supreme Court ruling on tariffs. Today, he published a more fulsome readout on LinkedIn, available here.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
The Supreme Court Struck Down IEEPA Tariffs – What Medtech Needs To Know
Now On Demand
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, learn what that means for your organization.